CDK4 and neoplasm: A high proportion of Treg cells in tumors predicted a poor clinical prognosis.38,39 Then, to investigate inhibitation of Treg cells after CDK4/6 PROTAC treatment in vivo, CT26 tumor bearing mice were employed.